PharmaCyte Biotech (PMCB) Stock Chart & Stock Price History $1.81 -0.06 (-3.21%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestTrends PharmaCyte Biotech Stock Price Performance5 Day Performance+0.56%1 Month Performance-5.24%3 Month Performance-7.65%6 Month Performance-14.62%Year-To-Date Performance-16.20%1 Year Performance-14.62% Receive PMCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. PMCB Stock Chart for Thursday, October, 31, 2024 PMCB Chart by TradingView PharmaCyte Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/31/2024$1.87$1.81-3.21%$2.03$1.8119,627 shs$13.90 million10/30/2024$1.97$1.87-5.08%$2.42$1.82724,993 shs$14.36 million10/29/2024$1.80$1.97+9.44%$2.00$1.7867,386 shs$15.13 million10/28/2024$1.80$1.80$2.01$1.7615,227 shs$13.82 million10/25/2024$1.79$1.80+0.56%$2.00$1.7769,343 shs$15.22 million10/24/2024$1.80$1.79-0.56%$1.80$1.7615,026 shs$15.13 million Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/23/2024$1.85$1.80-2.70%$1.96$1.6821,294 shs$15.22 million10/22/2024$1.80$1.85+2.78%$1.97$1.8126,200 shs$15.64 million10/21/2024$1.71$1.80+5.26%$1.92$1.7235,522 shs$15.22 million10/18/2024$1.70$1.71+0.59%$1.76$1.659,676 shs$14.46 million10/17/2024$1.71$1.70-0.58%$1.75$1.695,144 shs$14.37 million10/16/2024$1.72$1.71-0.58%$1.83$1.688,916 shs$14.46 million10/15/2024$1.73$1.72-0.58%$1.77$1.724,892 shs$14.54 million10/14/2024$1.73$1.73$1.82$1.7312,123 shs$14.62 million10/11/2024$1.73$1.73$1.76$1.7310,232 shs$13.29 million10/10/2024$1.75$1.73-1.14%$1.80$1.7313,462 shs$14.62 million10/09/2024$1.76$1.75-0.57%$1.94$1.7319,532 shs$14.79 million10/08/2024$1.76$1.76$1.87$1.768,083 shs$14.88 million10/07/2024$1.77$1.76-0.56%$1.88$1.7618,517 shs$14.88 million10/04/2024$1.73$1.77+2.31%$1.95$1.7618,433 shs$14.96 million10/03/2024$1.78$1.73-2.81%$1.82$1.726,226 shs$14.62 million10/02/2024$1.99$1.78-10.55%$2.05$1.7531,090 shs$15.05 million10/01/2024$1.91$1.99+4.19%$2.05$1.8063,939 shs$16.82 million09/30/2024$1.84$1.91+3.80%$2.06$1.8043,721 shs$16.15 million09/27/2024$1.80$1.84+2.22%$1.95$1.7818,277 shs$14.13 million09/26/2024$1.68$1.80+7.14%$1.94$1.7020,063 shs$13.82 million09/25/2024$1.79$1.68-6.15%$2.00$1.6457,315 shs$12.90 million09/24/2024$1.78$1.79+0.56%$1.95$1.7083,862 shs$15.13 million09/23/2024$1.62$1.78+9.88%$2.11$1.70140,636 shs$15.05 million09/20/2024$2.05$1.62-20.98%$2.00$1.5137,223 shs$13.69 million09/19/2024$1.93$2.05+6.22%$2.16$1.9225,580 shs$17.33 million09/18/2024$1.88$1.93+2.66%$2.11$1.7818,955 shs$16.31 million09/17/2024$1.91$1.88-1.57%$2.19$1.7932,271 shs$15.89 million09/16/2024$1.90$1.91+0.53%$1.99$1.7738,365 shs$16.15 million09/13/2024$1.81$1.90+4.97%$2.00$1.7058,103 shs$16.06 million09/12/2024$1.82$1.81-0.55%$1.82$1.791,536 shs$15.30 million09/11/2024$1.68$1.82+8.33%$1.82$1.629,226 shs$15.38 million09/10/2024$1.61$1.68+4.35%$1.73$1.5214,529 shs$14.20 million09/09/2024$1.59$1.61+1.26%$1.77$1.4524,329 shs$13.61 million09/06/2024$1.65$1.59-3.52%$1.69$1.5015,790 shs$13.44 millionBanking failure dead ahead (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now.09/05/2024$1.51$1.65+9.14%$1.65$1.5133,189 shs$13.93 million09/04/2024$1.47$1.51+2.72%$1.55$1.515,772 shs$11.64 million09/03/2024$1.53$1.47-3.92%$1.55$1.4710,173 shs$11.33 million09/02/2024$1.53$1.53$1.55$1.515,800 shs$11.80 million08/30/2024$1.57$1.53-2.55%$1.55$1.515,898 shs$12.93 million08/29/2024$1.53$1.57+2.61%$1.61$1.524,715 shs$13.27 million08/28/2024$1.48$1.53+3.38%$1.55$1.3915,623 shs$12.93 million08/27/2024$1.56$1.48-5.13%$1.66$1.3926,477 shs$12.51 million08/26/2024$1.66$1.56-6.02%$1.79$1.5626,413 shs$13.19 million08/23/2024$1.86$1.66-10.75%$1.82$1.6447,613 shs$14.03 million08/22/2024$1.83$1.86+1.64%$1.86$1.802,699 shs$15.72 million08/21/2024$1.81$1.83+1.10%$1.83$1.802,968 shs$15.47 million08/20/2024$1.85$1.81-2.16%$1.86$1.8014,828 shs$15.30 million08/19/2024$1.88$1.85-1.60%$1.90$1.8344,714 shs$15.64 million08/16/2024$1.88$1.87-0.53%$1.88$1.865,910 shs$15.81 million08/15/2024$1.89$1.88-0.53%$1.94$1.8514,028 shs$15.89 million08/14/2024$1.85$1.89+2.16%$1.90$1.825,294 shs$15.98 million08/13/2024$1.85$1.85$1.87$1.851,987 shs$15.64 million08/12/2024$1.89$1.85-1.86%$1.89$1.8418,818 shs$15.94 million08/09/2024$1.86$1.85-0.54%$1.93$1.845,637 shs$15.64 million08/08/2024$1.91$1.86-2.42%$1.93$1.8511,885 shs$15.72 million08/07/2024$1.95$1.91-2.25%$1.95$1.887,129 shs$16.11 million08/06/2024$1.92$1.95+1.56%$1.95$1.8810,013 shs$16.48 million08/05/2024$1.87$1.92+2.67%$1.95$1.8016,656 shs$16.23 million08/02/2024$1.99$1.87-6.03%$2.00$1.8721,469 shs$15.80 million08/01/2024$1.96$1.99+1.53%$1.99$1.964,521 shs$16.82 million07/31/2024$2.00$1.96-2.00%$2.03$1.9519,960 shs$16.56 million07/30/2024$2.00$2.00$2.01$1.958,061 shs$16.90 million Related Companies AVTE Stock Chart RAPT Stock Chart MURA Stock Chart STTK Stock Chart RPHM Stock Chart DTIL Stock Chart OSTX Stock Chart THTX Stock Chart OMGA Stock Chart VNRX Stock Chart Receive PMCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMCB) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCyte Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.